Peter Mac News

Award

Peter Mac staff recognised at the ANZGOG Awards

1 min read 24 March 2023

Three Peter Mac staff were recognised with prestigious awards at the Australia New Zealand Gynaecological Oncology Group (ANZGOG) Annual Scientific Meeting overnight.

Screen Shot 2023 03 24 at 12.08.30 pm

The awards highlight the outstanding contributions to improving life for women through cancer research.  

Congratulations to the following winners: 

  • Professor Linda Mileshkin was awarded the Clinical Trial Achievement Award in recognition of her significant contribution and leadership in research in gynaecological cancers. 

  • Professor David Bowtell received the ANZGOG Research Pioneer Award for his consistent innovation in ovarian cancer research. 

  • Dr Nikki Burdett was the winner of the Michael Friedlander Early Career Researcher Award for an outstanding early career researcher, with Dr Burdett recognised as one of the future leaders of ANZGOG. 

ANZGOG is the peak gynaecological cancer clinical trials organisation for Australia and New Zealand. Its purpose is to improve outcomes and quality of life for women with gynaecological cancer through conducting and promoting cooperative clinical trials and undertaking multidisciplinary research into the causes, prevention and treatments of gynaecological cancer. 

Peter Mac is proud to have three researchers recognised for their outstanding work and commitment to making a difference.  

Congratulations Prof Mileshkin, Prof Bowtell and Dr Burdett!